> 0 1 0 1 O
6 1 2 1 2 B-lower_bound
months 3 9 3 9 I-lower_bound
after 10 15 10 15 O
completion 16 26 16 26 O
of 27 29 27 29 O
adjuvant 30 38 30 38 B-treatment
therapy 39 46 39 46 I-treatment
( 47 48 47 48 O
including 48 57 48 57 O
chemotherapy 58 70 58 70 B-treatment
and/or 71 77 71 77 O
radiotherapy 78 90 78 90 B-treatment
) 90 91 90 91 O

Ability 0 7 92 99 O
to 8 10 100 102 O
understand 11 21 103 113 O
and 22 25 114 117 O
the 26 29 118 121 O
willingness 30 41 122 133 O
to 42 44 134 136 O
sign 45 49 137 141 O
a 50 51 142 143 O
written 52 59 144 151 O
informed 60 68 152 160 O
consent 69 76 161 168 O
document 77 85 169 177 O
and 86 89 178 181 O
consent 90 97 182 189 O
to 98 100 190 192 O
the 101 104 193 196 O
serial 105 111 197 203 O
nature 112 118 204 210 O
of 119 121 211 213 O
the 122 125 214 217 O
proposed 126 134 218 226 O
PANGEA 135 141 227 233 B-treatment
treatment 142 151 234 243 I-treatment
with 152 156 244 248 O
first 157 162 249 254 O
, 162 163 254 255 O
second 164 170 256 262 O
and 171 174 263 266 O
third 175 180 267 272 O
line 181 185 273 277 O
therapy 186 193 278 285 B-treatment
as 194 196 286 288 O
tolerated 197 206 289 298 O

Both 0 4 299 303 O
men 5 8 304 307 B-gender
and 9 12 308 311 O
women 13 18 312 317 B-gender
and 19 22 318 321 O
members 23 30 322 329 O
of 31 33 330 332 O
all 34 37 333 336 O
races 38 43 337 342 O
and 44 47 343 346 O
ethnic 48 54 347 353 O
groups 55 61 354 360 O
are 62 65 361 364 O
eligible 66 74 365 373 O
for 75 78 374 377 O
this 79 83 378 382 O
trial 84 89 383 388 O

Cardiac 0 7 389 396 B-clinical_variable
Ejection 8 16 397 405 I-clinical_variable
Fraction 17 25 406 414 I-clinical_variable
> 26 27 415 416 O
50 27 29 416 418 B-lower_bound
% 29 30 418 419 I-lower_bound
( 31 32 420 421 O
for 32 35 421 424 O
HER2 36 40 425 429 B-clinical_variable
+ 40 41 429 430 O
patients 42 50 431 439 O
) 50 51 439 440 O
as 52 54 441 443 O
assessed 55 63 444 452 O
by 64 66 453 455 O
echocardiogram 67 81 456 470 B-treatment
, 81 82 470 471 O
MUGA 83 87 472 476 B-treatment
scan 88 92 477 481 I-treatment
, 92 93 481 482 O
or 94 96 483 485 O
cardiac 97 104 486 493 B-treatment
MRI 105 108 494 497 I-treatment

Consent 0 7 498 505 O
to 8 10 506 508 O
baseline 11 19 509 517 O
metastatic 20 30 518 528 B-cancer
and 31 34 529 532 O
progressive 35 46 533 544 B-chronic_disease
disease 47 54 545 552 I-chronic_disease
biopsy 55 61 553 559 O
( 62 63 560 561 O
of 63 65 561 563 O
metastatic 66 76 564 574 O
/ 76 77 574 575 O
progressing 77 88 575 586 O
lesion 89 95 587 593 O
) 95 96 593 594 O
for 97 100 595 598 O
enabling 101 109 599 607 O
biomarker 110 119 608 617 O
assessment 120 130 618 628 O
and 131 134 629 632 O
treatment 135 144 633 642 B-treatment
assignment 145 155 643 653 O
( 156 157 654 655 O
at 157 159 655 657 O
each 160 164 658 662 O
time 165 169 663 667 O
point 170 175 668 673 O
- 176 177 674 675 O
baseline 178 186 676 684 O
, 186 187 684 685 O
PD1 188 191 686 689 B-clinical_variable
, 191 192 689 690 O
PD2 193 196 691 694 B-clinical_variable
, 196 197 694 695 O
PD3 198 201 696 699 B-clinical_variable
) 201 202 699 700 O
as 203 205 701 703 O
well 206 210 704 708 O
as 211 213 709 711 O
for 214 217 712 715 O
correlative 218 229 716 727 O
studies 230 237 728 735 O

Histologically 0 14 736 750 O
confirmed 15 24 751 760 O
metastatic 25 35 761 771 B-cancer
gastric 36 43 772 779 I-cancer
or 44 46 780 782 O
esophagogastric 47 62 783 798 B-chronic_disease
junction 63 71 799 807 I-chronic_disease
( 72 73 808 809 O
type 73 77 809 813 O
I 78 79 814 815 O
, 79 80 815 816 O
II 80 82 816 818 O
, 82 83 818 819 O
III 83 86 819 822 O
Siewert 87 94 823 830 O
) 94 95 830 831 O
adenocarcinoma 96 110 832 846 B-cancer

INR 0 3 847 850 B-clinical_variable
: 3 4 850 851 O
< 5 6 852 853 O
1.5 7 10 854 857 B-upper_bound
( 11 12 858 859 O
patients 12 20 859 867 O
on 21 23 868 870 O
warfarin 24 32 871 879 B-treatment
need 33 37 880 884 O
to 38 40 885 887 O
be 41 43 888 890 O
converted 44 53 891 900 O
to 54 56 901 903 O
LMWH 57 61 904 908 B-treatment
during 62 68 909 915 O
study 69 74 916 921 O
participation 75 88 922 935 O
to 89 91 936 938 O
be 92 94 939 941 O
eligible 95 103 942 950 O
) 103 104 950 951 O

Measurable 0 10 952 962 O
metastatic 11 21 963 973 B-cancer
disease 22 29 974 981 I-cancer

Must 0 4 982 986 O
be 5 7 987 989 O
amenable 8 16 990 998 O
to 17 19 999 1001 O
ultrasound 20 30 1002 1012 B-treatment
or 31 33 1013 1015 O
CT 34 36 1016 1018 B-treatment
- 36 37 1018 1019 I-treatment
guided 37 43 1019 1025 I-treatment
biopsy 44 50 1026 1032 I-treatment
of 51 53 1033 1035 O
one 54 57 1036 1039 O
metastatic 58 68 1040 1050 B-cancer
lesion 69 75 1051 1057 I-cancer

Newly 0 5 1058 1063 O
- 5 6 1063 1064 O
diagnosed 6 15 1064 1073 O
chemo 16 21 1074 1079 O
- 21 22 1079 1080 O
naÃ¯ve 22 27 1080 1085 O
or 28 30 1086 1088 O
recurrent 31 40 1089 1098 O
after 41 46 1099 1104 O
curative 47 55 1105 1113 B-treatment
- 55 56 1113 1114 I-treatment
intent 56 62 1114 1120 I-treatment
surgery 63 70 1121 1128 I-treatment

No 0 2 1129 1131 O
CVA 3 6 1132 1135 B-chronic_disease
within 7 13 1136 1142 O
6 14 15 1143 1144 B-upper_bound
months 16 22 1145 1151 I-upper_bound

No 0 2 1152 1154 O
currently 3 12 1155 1164 O
active 13 19 1165 1171 O
second 20 26 1172 1178 O
malignancy 27 37 1179 1189 B-cancer

No 0 2 1190 1192 O
diarrhea 3 11 1193 1201 B-clinical_variable
> 12 13 1202 1203 O
grade 14 19 1204 1209 B-lower_bound
2 20 21 1210 1211 I-lower_bound
at 22 24 1212 1214 O
baseline 25 33 1215 1223 O

No 0 2 1224 1226 O
peripheral 3 13 1227 1237 B-clinical_variable
edema 14 19 1238 1243 I-clinical_variable
> 20 21 1244 1245 O
grade 22 27 1246 1251 B-lower_bound
2 28 29 1252 1253 I-lower_bound
at 30 32 1254 1256 O
baseline 33 41 1257 1265 O

No 0 2 1266 1268 O
peripheral 3 13 1269 1279 B-chronic_disease
neuropathy 14 24 1280 1290 I-chronic_disease
> 25 26 1291 1292 O
grade 27 32 1293 1298 B-lower_bound
2 33 34 1299 1300 I-lower_bound
at 35 37 1301 1303 O
baseline 38 46 1304 1312 O

No 0 2 1313 1315 O
prior 3 8 1316 1321 B-treatment
treatment 9 18 1322 1331 I-treatment
with 19 23 1332 1336 I-treatment
any 24 27 1337 1340 I-treatment
targeted 28 36 1341 1349 I-treatment
agent 37 42 1350 1355 I-treatment

No 0 2 1356 1358 O
uncontrolled 3 15 1359 1371 O
intercurrent 16 28 1372 1384 B-chronic_disease
illness 29 36 1385 1392 I-chronic_disease
or 37 39 1393 1395 O
infection 40 49 1396 1405 O

Patients 0 8 1406 1414 O
who 9 12 1415 1418 O
have 13 17 1419 1423 O
started 18 25 1424 1431 O
first 26 31 1432 1437 B-treatment
line 32 36 1438 1442 I-treatment
mFOLFOX6 37 45 1443 1451 I-treatment
therapy 46 53 1452 1459 I-treatment
( 54 55 1460 1461 O
+ 55 56 1461 1462 O
/-trastuzumab 56 69 1462 1475 O
for 70 73 1476 1479 O
HER2 74 78 1480 1484 B-cancer
amplified 79 88 1485 1494 I-cancer
tumors 89 95 1495 1501 I-cancer
) 95 96 1501 1502 O
may 97 100 1503 1506 O
be 101 103 1507 1509 O
considered 104 114 1510 1520 O
for 115 118 1521 1524 O
trial 119 124 1525 1530 O
participation 125 138 1531 1544 O
if 139 141 1545 1547 O
they 142 146 1548 1552 O
have 147 151 1553 1557 O
received 152 160 1558 1566 O
no 161 163 1567 1569 O
more 164 168 1570 1574 O
than 169 173 1575 1579 O
4 174 175 1580 1581 B-upper_bound
doses 176 181 1582 1587 I-upper_bound
of 182 184 1588 1590 O
therapy 185 192 1591 1598 O
at 193 195 1599 1601 O
the 196 199 1602 1605 O
time 200 204 1606 1610 O
of 205 207 1611 1613 O
consent 208 215 1614 1621 O
and 216 219 1622 1625 O
screening 220 229 1626 1635 O

Willingness 0 11 1636 1647 B-contraception_consent
to 12 14 1648 1650 I-contraception_consent
use 15 18 1651 1654 I-contraception_consent
effective 19 28 1655 1664 I-contraception_consent
and 29 32 1665 1668 I-contraception_consent
reliable 33 41 1669 1677 I-contraception_consent
methods 42 49 1678 1685 I-contraception_consent
of 50 52 1686 1688 I-contraception_consent
contraception 53 66 1689 1702 I-contraception_consent
( 67 68 1703 1704 O
For 68 71 1704 1707 O
appropriate 72 83 1708 1719 O
methods 84 91 1720 1727 O
of 92 94 1728 1730 O
contraception 95 108 1731 1744 O
considered 109 119 1745 1755 O
acceptable 120 130 1756 1766 O
see 131 134 1767 1770 O
Appendix 135 143 1771 1779 O
B 144 145 1780 1781 O
) 145 146 1781 1782 O

no 0 2 1783 1785 O
recent 3 9 1786 1792 O
MI 10 12 1793 1795 B-chronic_disease
within 13 19 1796 1802 O
6 20 21 1803 1804 B-upper_bound
months 22 28 1805 1811 I-upper_bound

total 0 5 1812 1817 B-clinical_variable
bilirubin 6 15 1818 1827 I-clinical_variable
< 16 17 1828 1829 O
1.5 18 21 1830 1833 B-lower_bound
x 22 23 1834 1835 I-lower_bound
ULN 24 27 1836 1839 I-lower_bound
, 27 28 1839 1840 O
< 29 30 1841 1842 O
1.8 30 33 1842 1845 B-lower_bound
x 34 35 1846 1847 I-lower_bound
ULN 36 39 1848 1851 I-lower_bound
with 40 44 1852 1856 O
liver 45 50 1857 1862 B-cancer
metastases 51 61 1863 1873 I-cancer

